OSCR vs PARAP
Comparison between Oscar Health Inc - Class A (OSCR, Company) and Paramount Global Conv Pfd (PARAP, Company).
OSCR vs PARAP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
OSCR
$8.98B
Winner
PARAP
$8.99B
Max Drawdown
OSCR
94.15%
Winner
PARAP
77.73%
Sharpe Ratio
Winner
OSCR
1.23
PARAP
-0.81
5Y Beta
OSCR
1.02
PARAP
N/A
Industry
OSCR
Healthcare Plans
PARAP
N/A
P/E Ratio
OSCR
15.45
Winner
PARAP
-1320.95
Forward P/E
OSCR
588.24
PARAP
N/A
PEG Ratio
OSCR
0.05
PARAP
N/A
Debt to Equity
Winner
OSCR
25.90%
PARAP
65.40%
Free Cash Flow Yield
Winner
OSCR
31.58%
PARAP
8.96%
P/S Ratio
OSCR
0.68
Winner
PARAP
0.30
P/B Ratio
OSCR
5.66
Winner
PARAP
0.39
OSCR vs PARAP - Historical Returns
Returns include dividend reinvestment.
1M
OSCR
-10.35%
Winner
PARAP
+4.39%
3M
Winner
OSCR
+33.68%
PARAP
-19.91%
6M
Winner
OSCR
+127.94%
PARAP
-7.79%
1Y
Winner
OSCR
+84.04%
PARAP
-37.02%
5Y(CAGR)
OSCR
+12.98%
PARAP
N/A
Max(CAGR)
Winner
OSCR
-3.99%
PARAP
-32.88%
OSCR vs PARAP - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | OSCR | PARAP |
|---|---|---|
| 2026 | +86.37% | N/A |
| 2025 | +6.05% | N/A |
| 2024 | +47.69% | -18.72% |
| 2023 | +271.95% | -6.69% |
| 2022 | -69.74% | -45.29% |
| 2021 | -77.44% | N/A |
OSCR vs PARAP Drawdown Comparison
The maximum drawdown for OSCR was -94.15%, occurring on Dec 21, 2022. This drawdown has not yet recovered.
The maximum drawdown for PARAP was -66.20%, occurring on Mar 5, 2024. This drawdown has not yet recovered.
The current OSCR drawdown is -24.12%. The current PARAP drawdown is -61.42%.
| Rank | OSCR | PARAP |
|---|---|---|
| #1 | -94.15% Mar 10, 2021 - Dec 21, 2022 | -66.20% Mar 3, 2022 - Mar 5, 2024 |
| #2 | -10.92% Mar 3, 2021 - Mar 10, 2021 | -4.00% Feb 17, 2022 - Feb 25, 2022 |
Correlation
Correlation between OSCR and PARAP is -0.27 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.27
-101
Select Stocks to Compare
Popular: OSCR vs SPYPARAP vs SPY
More Comparisons
Compare with similar stocks